Advertisement
The leading life science news channel in the Nordic region.
Collaboration - May 7, 2024
EIT Health Scandinavia has presented a hub that connects researchers, clinicians and industry with European biobanks and health data registries. The platform, EIT Health Biobanks and Health Data Registries, provides easy access to and exchange of information on European biobanks and health data registries which are crucial for promoting medical research and innovation, states EIT […]
MedTech Business - May 7, 2024
Sectra’s digital pathology solution together with Leica Biosystems, Imaging, Inc.’s Aperio GT 450 DX have received a 510(k) clearance by the FDA. This is the first time an FDA clearance within digital pathology allows the use of DICOM images for pathology diagnostics, which marks a significant step towards standardization in this field, the companies state. […]
Global report - May 7, 2024
Karolinska Institutet’s president, Annika Östman Wernerson, and vice-president, Martin Bergö, have written an open letter to Sweden’s minister for foreign affairs and minister for education, calling on them to use all means available to increase the pressure on Iran to free Dr Djalali and other Swedish citizens. Eight years ago, on 25 April, Ahmadreza Djalali […]
Business article - May 7, 2024
Astra Zeneca is terminating 200 jobs at the facility in Mölndal, reports Göteborgs-Posten. In a written comment, the company highlights that the number of employees has increased by several hundred in Mölndal in recent years and that it is not about any cuts. “On the contrary, we continue to grow and constantly recruit new employees, […]
Clinical Trials - May 7, 2024
After a positive initial safety evaluation, the pioneering STEM-PD (stem cell-based transplant for Parkinson’s disease) clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived from stem cells. A […]
Global report - May 6, 2024
The new partnership will support critical scientific R&D for global health and is focused on advancing solutions that are accessible and affordable to people in low- and middle-income countries. The three-year initiative was announced at the Novo Nordisk Foundation’s Global Science Summit in Denmark, where each organization committed USD 100 million, for a total of […]
Collaboration - May 6, 2024
Researchers at Karolinska Institutet have developed a web-based platform that provides new insight into the human body at the cellular level. The new Single Cell Atlas (SCA) is based on analyses of thousands of human tissue samples from 125 different adult and fetal tissues. The researchers combined eight omics technologies, including single-cell RNA sequencing, whole-genome […]
Biotech Business - May 1, 2024
Genmab and Pfizer have announced that the FDA has approved the supplemental Biologics License Application for TIVDAK for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. This FDA action converts the September 2021 accelerated approval of TIVDAK to a full approval. TIVDAK is the first antibody-drug […]
Business article - May 1, 2024
Jennie Ekbeck, former CEO of Umeå Biotech Incubator, is now working for the business incubator Lead that supports promising start-ups in Östergötland. Her mission is to transform the academic potential in Linköping and Norrköping into flourishing companies. Jennie Ekbeck has a background in biomedicine and she has also studied business economics and law at Umeå […]
Pharma Business - April 30, 2024
Medivir’s selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease Designation (RPDD) as well as Orphan Drug Designation (ODD) for the treatment of Legg-Calvé-Perthes Disease (LCPD). The FDA defines a rare pediatric disease as a serious or life-threatening disease in which the disease manifestations primarily affect individuals aged from birth to 18 years […]
This site uses cookies